Skip to main content
Equibles
JNJ logo

JNJ · Johnson & Johnson · Metrics

Track JNJ — free

Use JNJ with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research JNJ.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$271.43 +1.21 (+0.45%)
S&P 500 member Russell 1000 member Dow 30 member Rebalance outlook locked
Market Cap
$641.80B
Shares
2.41B

JNJ metrics

89 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$270.22
Market cap
$641.80B

Price action

20 metrics
Price change (1W)
+0.1%
Price change (30D)
-2.2%
Price change (3M)
+14.1%
Price change (6M)
+12.6%
Price change (YTD)
+29.2%
Price change (1Y)
+51.5%
Trailing year
Price change (5Y)
+61.8%
52-week high
$278.43
52-week low
$174.16
Change from 52-week high
-4.0%
Change from 52-week low
+53.5%
Annualized volatility
19.2%
Annualized volatility (3M)
25.0%
Beta
-0.2
RSI (14D)
50.9
Price vs SMA 50
+1.7%
Price vs SMA 200
+12.3%
Avg volume (3M)
7.56M
Relative volume
0.7
Average dollar volume
$1.95B

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
2.41B

Valuation

12 metrics
P / E (TTM)
31.0
Trailing earnings · reciprocal yield 3.2%
PEG ratio
—
EV / revenue
6.8×
reciprocal yield 14.6%
EV / EBITDA
24.6×
reciprocal yield 4.1%
EV / EBIT
28.9×
reciprocal yield 3.5%
P / sales
6.6×
reciprocal yield 15.3%
P / book
7.6
reciprocal yield 13.2%
FCF yield
3.5%
TTM · current market cap
Buyback yield
1.3%
P / FCF
28.9
reciprocal yield 3.5%
P / operating cash flow
23.2
reciprocal yield 4.3%
Earnings yield
3.3%

Historical valuation

8 metrics
P / E historical average (3Y)
20.3×
reciprocal yield 4.9%
P / E historical average (5Y)
22.1×
reciprocal yield 4.5%
EV / revenue historical average (3Y)
4.9×
reciprocal yield 20.2%
EV / revenue historical average (5Y)
4.9×
reciprocal yield 20.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.3%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-13
Last earnings
2026-07-15

Profitability

9 metrics
Gross margin
67.9%
Operating margin
—
Trailing 12 months
Net margin
21.5%
Gross profit (TTM)
$66.50B
Operating profit (TTM)
$21.77B
Net income (TTM)
$21.04B
Trailing 12 months
Diluted EPS (TTM)
$8.61
FCF margin
22.7%
Effective tax rate
16.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+6.6%
Year over year
Net income growth YoY
-0.1%
Revenue (TTM)
$97.93B
Trailing 12 months
EPS growth YoY
-0.9%
Shares change YoY
+0.9%
Year over year · more shares
Revenue CAGR (3Y)
+5.6%
Revenue CAGR (5Y)
+2.7%
EPS CAGR (3Y)
+17.9%
EPS CAGR (5Y)
+14.9%
FCF CAGR (3Y)
+4.7%
FCF CAGR (5Y)
-0.5%

Quality

14 metrics
Return on equity
24.8%
Return on assets
10.5%
Debt / equity
0.6
Current ratio
1.1
EBITDA (TTM)
$25.54B
Free cash flow (TTM)
$22.24B
Quick ratio
0.8
Interest coverage
—
Net debt / EBITDA
-0.5
Return on invested capital
—
Trailing 12 months
Net cash
−$28.28B
Latest balance sheet
Cash & equivalents
$20.42B
Total assets
$201.06B
Total debt
$49.04B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$27.61B
Capital expenditures (TTM)
$5.36B
R&D (TTM)
$548.00M
SG&A (TTM)
$25.14B
Stock compensation (TTM)
$1.41B
R&D / revenue
0.6%
Stock compensation / revenue
1.4%

Ownership (13F)

3 metrics
13F filers
4,708
13F filer change QoQ
+33
Institutional ownership
76.1%

Short interest

3 metrics
Short interest
0.9%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
49 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$67.78M
Insider-sentiment score
18 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 200406 CUSIP 478160104 13F (30d) 155 filings 78 filers Visit website Investor relations